Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,340.00    1.00 (0.04%)
Bid:
2,342.00
Ask:
2,344.00
Spread: 2.00 (0.085%)
Market Cap: £3.91b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

Share Repurchase Programme

1 May 2025 07:05

RNS Number : 9278G
Whitbread PLC
01 May 2025
 

 

SHARE REPURCHASE PROGRAMME

 

As announced in today's full year preliminary results announcement, Whitbread PLC ('Whitbread' or the 'Company') is commencing a share buy-back programme of up to a maximum consideration of £250 million (the 'Programme'). The purpose of the Programme is to reduce the capital of Whitbread by returning surplus capital to shareholders and it is expected that the implementation of the Programme will enhance earnings per share. Whitbread has instructed Morgan Stanley & Co International Plc ('Morgan Stanley') to execute the Programme.

 

Whitbread has entered into a non-discretionary and irrevocable instruction with Morgan Stanley in relation to the purchase by Morgan Stanley, acting as riskless principal during the period commencing today and ending no later than 30 April 2026, of the Company's Ordinary Shares of 76 122/153 pence each ('Ordinary Shares') for an aggregate purchase price of up to but not greater than £250 million.

 

Morgan Stanley shall make a simultaneous on-sale of Ordinary Shares purchased under the instruction to Whitbread. Morgan Stanley will make its trading decisions in relation to the Programme independently of, and uninfluenced by, Whitbread.

 

Prior to the Company's Annual General Meeting scheduled to be held on 19 June 2025 (the '2025 AGM') the maximum number of Ordinary Shares that can be purchased under the Programme is 13,250,263 Ordinary Shares (based on authority granted at the Company's Annual General Meeting held on 18 June 2024 (the '2024 AGM')). This existing authority to buy back shares granted at the 2024 AGM expires at the conclusion of the 2025 AGM (or, if earlier, 18 September 2025). The continuation of the Programme after the 2025 AGM is subject to purchases of Shares pursuant to the Programme remaining within the shareholder authority (if any) for the Company to purchase its Shares that is granted at the 2025 AGM.

 

Any purchase of Ordinary Shares made by Morgan Stanley in relation to the Programme will be carried out on the London Stock Exchange plc, Cboe Europe Limited or Aquis Stock Exchange Limited. The buy-back by Whitbread will be executed in accordance with the UK Listing Rules and Whitbread's general authority (from time to time) to make market purchases of Ordinary Shares. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. Whitbread will announce any purchase by it of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. Ordinary Shares purchased under the Programme will be cancelled or (to the extent permitted by law) held in treasury.

 

Morgan Stanley may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by Morgan Stanley as a result of or as part of the Programme, but Morgan Stanley will continue to make any disclosures they are otherwise legally required to make.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

Media - Brunswick Whitbread@brunswickgroup.com

Tim Danaher +44 (0) 20 7404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXLEDDFSEFA
Date   Source Headline
27th Apr 20238:59 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20239:07 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20234:45 pmRNSDirector/PDMR Shareholding
25th Apr 20237:04 amRNSShare repurchase programme
25th Apr 20237:00 amRNSPreliminary Results Announcement
21st Apr 20239:41 amRNSHolding(s) in Company
20th Apr 20239:01 amRNSHolding(s) in Company
19th Apr 20239:10 amRNSHolding(s) in Company
18th Apr 202311:41 amRNSHolding(s) in Company
17th Apr 20239:23 amRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
11th Apr 20239:01 amRNSHolding(s) in Company
11th Apr 20238:59 amRNSHolding(s) in Company
3rd Apr 20233:05 pmRNSTotal Voting Rights
3rd Mar 202312:08 pmRNSDirector/PDMR Shareholding
1st Mar 20232:37 pmRNSTotal Voting Rights
28th Feb 202311:31 amRNSDirector/PDMR Shareholding
27th Feb 20233:58 pmRNSDirector/PDMR Shareholding
27th Feb 20233:58 pmRNSDirector/PDMR Shareholding
15th Feb 20232:28 pmRNSDirector/PDMR Shareholding
8th Feb 20232:51 pmRNSDirector/PDMR Shareholding
1st Feb 20232:38 pmRNSTotal Voting Rights
1st Feb 20231:17 pmRNSDirector/PDMR Shareholding
25th Jan 202310:01 amRNSBlock listing Interim Review
24th Jan 20239:02 amRNSDirectorate Change
17th Jan 202312:26 pmRNSDirector/PDMR Shareholding
16th Jan 20234:42 pmRNSDirector/PDMR Shareholding
13th Jan 20233:55 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSQ3 FY23 Trading Update
9th Jan 20234:29 pmRNSDirectorate Change
20th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 202211:46 amRNSAppointment of Dominic Paul as CEO
1st Dec 20221:54 pmRNSTotal Voting Rights
15th Nov 20224:21 pmRNSDirector/PDMR Shareholding
7th Nov 20224:21 pmRNSDirector/PDMR Shareholding
27th Oct 202211:19 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSWhitbread Interim Results
3rd Oct 20224:23 pmRNSHolding(s) in Company
3rd Oct 20224:22 pmRNSHolding(s) in Company
3rd Oct 202210:32 amRNSTotal Voting Rights
1st Sep 202210:36 amRNSTotal Voting Rights
24th Aug 20229:51 amRNSDirector/PDMR Shareholding
24th Aug 20228:00 amRNSMajor freehold purchase in central London
1st Aug 202211:00 amRNSTotal Voting Rights
25th Jul 20229:07 amRNSBlock listing Interim Review
21st Jul 20227:10 amRNSDirector Declaration
11th Jul 20221:39 pmRNSDirector/PDMR Shareholding
1st Jul 20223:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.